Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -4.43 | -2.18 | 0.43 | -1.31 |
| FCF Yield | -1.68% | -1.55% | 4.54% | 3.27% |
| EV / EBITDA | 23.35 | 29.83 | 19.33 | 17.70 |
| Quality | ||||
| ROIC | 1.94% | 3.99% | 5.70% | 4.26% |
| Gross Margin | 46.97% | 41.34% | 42.77% | 40.59% |
| Cash Conversion Ratio | 2.03 | 1.32 | 2.82 | 3.62 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.14% | -5.75% | 1.57% | 9.34% |
| Free Cash Flow Growth | 28.11% | -138.72% | 46.80% | 33.20% |
| Safety | ||||
| Net Debt / EBITDA | 0.07 | 0.29 | -0.57 | 0.31 |
| Interest Coverage | 2.25 | 5.76 | 7.23 | 6.05 |
| Efficiency | ||||
| Inventory Turnover | 2.35 | 2.13 | 1.90 | 2.44 |
| Cash Conversion Cycle | 134.57 | 93.77 | 44.84 | 66.03 |